CytoDyn, Inc. (CYDY)
CytoDyn Market Cap : 363.88M for Nov. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 16, 2026 | 363.88M |
| November 13, 2026 | 359.23M |
| November 12, 2026 | 347.45M |
| November 11, 2026 | 337.26M |
| November 10, 2026 | 345.85M |
| November 09, 2026 | 344.32M |
| November 06, 2026 | 334.21M |
| November 05, 2026 | 328.63M |
| November 04, 2026 | 332.32M |
| November 03, 2026 | 329.12M |
| November 02, 2026 | 320.10M |
| October 30, 2026 | 319.96M |
| October 29, 2026 | 327.23M |
| October 28, 2026 | 308.32M |
| October 27, 2026 | 316.61M |
| October 26, 2026 | 347.95M |
| October 23, 2026 | 378.13M |
| October 22, 2026 | 348.90M |
| October 21, 2026 | 356.46M |
| October 20, 2026 | 363.73M |
| October 19, 2026 | 363.59M |
| October 16, 2026 | 331.96M |
| October 15, 2026 | 298.69M |
| October 14, 2026 | 290.87M |
| October 13, 2026 | 289.24M |
| Date | Value |
|---|---|
| October 12, 2026 | 290.87M |
| October 09, 2026 | 290.87M |
| October 08, 2026 | 276.76M |
| October 07, 2026 | 274.57M |
| October 06, 2026 | 274.70M |
| October 05, 2026 | 274.70M |
| October 02, 2026 | 274.70M |
| October 01, 2026 | 273.33M |
| September 30, 2026 | 281.57M |
| September 29, 2026 | 277.45M |
| September 28, 2026 | 297.39M |
| September 25, 2026 | 311.79M |
| September 24, 2026 | 292.61M |
| September 23, 2026 | 285.69M |
| September 22, 2026 | 282.26M |
| September 21, 2026 | 298.81M |
| September 18, 2026 | 293.55M |
| September 17, 2026 | 288.44M |
| September 16, 2026 | 280.20M |
| September 15, 2026 | 275.66M |
| September 14, 2026 | 271.68M |
| September 11, 2026 | 271.34M |
| September 10, 2026 | 260.97M |
| September 09, 2026 | 274.43M |
| September 08, 2026 | 273.49M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.163B |
| Alnylam Pharmaceuticals, Inc. | 20.96B |
| Anika Therapeutics, Inc. | 172.65M |
| Savara, Inc. | 919.77M |
| Arrowhead Pharmaceuticals, Inc. | 6.070B |
Market Cap Related Metrics
| PEG Ratio | -0.0394 |
| Price | 0.2502 |
| Earnings Yield | -17.71% |
| PEGY Ratio | -0.0394 |